✦ LIBER ✦

Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction

✍ Scribed by Lawrence R. Coia; Anthony R. Paul; Paul F. Engstrom

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 641 KB
Volume: 61
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19880215)61:4<643::aid-cncr2820610404>3.0.co;2-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adenocarcinoma of the esophagus and gast

Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy

✍ Robert Fein; David P. Kelsen; Nancy Geller; Manjit Bains; Patricia McCormack; Mu 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB

Sequential infusional 5-fluorouracil fol

Sequential infusional 5-fluorouracil followed by concomitant radiation for tumors of the esophagus and gastroesophageal junction

✍ Jacob J. Lokich; Michael Shea; John Chaffey 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Preoperative induction of CPT-11 and cis

Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction

✍ Jaffer A. Ajani; Garrett Walsh; Ritsuko Komaki; Jeff Morris; Stephen G. Swisher; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract ## BACKGROUND Patients with localized esophageal carcinoma often develop locoregional and distant disease recurrence. The current study investigated the outcome of a new chemotherapy combination as induction therapy before chemoradiotherapy. ## METHODS Forty‐three patients with resec

Genomic analysis of early adenocarcinoma

Genomic analysis of early adenocarcinoma of the esophagus or gastroesophageal junction: Tumor progression is associated with alteration of 1q and 8p sequences

✍ Herman van Dekken; Josiane C. Wink; Kees J. Vissers; Ronald van Marion; Linetta 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB

## Abstract Early (T1 stage) adenocarcinoma of the esophagus or gastroesophageal junction is a potentially curable disease. We analyzed the genomic spectra of 33 early neoplastic lesions after subdividing the tumors into six depths of invasion (T1–mucosal, m1–m3; T1–submucosal, sm1–sm3). Two subgro

Unresectable nonmetastatic squamous cell

Unresectable nonmetastatic squamous cell carcinoma of the esophagus managed by sequential chemotherapy (cisplatin and bleomycin) and radiation therapy

✍ Miguel A. Izquierdo; Eugenio Marcuello; Gerardo Gomez De Segura; Remedios Blanco 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

High dose chemoradiotherapy followed by

High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction : Results of a Phase II study of the Eastern Cooperative Oncology Group

✍ Steven M. Keller; Louise M. Ryan; Lawrence R. Coia; Phuong Dang; David J. Vaught 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## BACKGROUND. To assess the toxicity, local response, and survival associated with multimodality therapy in a cooperative group setting, patients with biopsy-proven clinical Stage I or II adenocarcinoma of the esophagus (staged according to 1983 American Joint Committee on Cancer criteria) or gast